Literature DB >> 30036673

An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11.

P Stefanelli1, C Fazio2, P Vacca2, A Palmieri2, L Ambrosio2, A Neri2, A Piana3, P Castiglia3, F Argiolas4, S Santus5, L Masala6, G Steri5, F Riccardo2, S Iannazzo7, F P Maraglino7, C D'Amario7, G Rezza2.   

Abstract

OBJECTIVES: The aim was to investigate an outbreak of invasive meningococcal disease (IMD) in Southern Sardinia.
METHODS: Epidemiological and microbiological investigations were performed. The latter included antimicrobial susceptibility testing and whole-genome sequencing (WGS).
RESULTS: Seven individuals with severe IMD were found to be infected with serogroup B (MenB) Neisseria meningitidis in the first quarter of 2018. Five of the seven cases (five males; mean age 19 years; range 18-21 years; CFR 40%) were due to a unique strain B:P1.5-1,10-8:F3-6:ST-11(cc11), probably switched from the hypervirulent C-cc11, as confirmed by WGS. All five patients had attended the same nightclub in the 2 weeks prior to symptom onset. Public health measures, including chemoprophylaxis of contacts and active immunization against MenB, were implemented.
CONCLUSIONS: We observed five IMD cases due to the same switched MenB strain. The hypervirulent B:P1.5-1,10-8:F3-6:ST-11(cc11) strain, probably switched from C-cc11, is of concern due to the observed high virulence and case fatality rates. All the patients shared the same place of probable exposure. The molecular characterization of the invasive strain allowed the outbreak to be confirmed, which was then controlled through timely public health action.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Capsular switching; Hypervirulent; Invasive meningococcal disease; Italy; Neisseria meningitides; Outbreak; Whole-genome sequencing

Mesh:

Substances:

Year:  2018        PMID: 30036673     DOI: 10.1016/j.cmi.2018.07.014

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by Neisseria meningitidis C:P1.5-1,10-8:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020.

Authors:  Cecilia Fazio; Laura Daprai; Arianna Neri; Marcello Tirani; Paola Vacca; Milena Arghittu; Luigina Ambrosio; Danilo Cereda; Maria Gramegna; Annapina Palmieri; Anna Carannante; Maria Rosa Bertoli; Lucia Crottogini; Giorgio Gennati; Eugenia Quinz; Livia Trezzi; Andrea Ciammaruconi; Silvia Fillo; Antonella Fortunato; Giovanni Rezza; Florigio Lista; Paola Stefanelli
Journal:  Euro Surveill       Date:  2022-06

2.  The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.

Authors:  Anna D Loenenbach; Arie van der Ende; Hester E de Melker; Elisabeth A M Sanders; Mirjam J Knol
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

3.  Molecular characterization of Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease in Colombia from 2013 to 2016.

Authors:  Jaime Moreno; Zonia Alarcon; Eliana Parra; Carolina Duarte; Olga Sanabria; Diego Prada; Jean Marc Gabastou
Journal:  PLoS One       Date:  2020-07-14       Impact factor: 3.240

4.  cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland.

Authors:  Robert M Mulhall; Desiree E Bennett; Holly B Bratcher; Keith A Jolley; James E Bray; Piaras P O'Lorcain; Suzanne M Cotter; Martin C J Maiden; Robert J Cunney
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

5.  Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.

Authors:  S Igidbashian; L Bertizzolo; A Tognetto; C Azzari; P Bonanni; P Castiglia; M Conversano; S Esposito; G Gabutti; G Icardi; P L Lopalco; F Vitale; S Parisi; G Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2020-07-04

6.  Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.

Authors:  Anna Carannante; Cecilia Fazio; Arianna Neri; Florigio Lista; Silvia Fillo; Andrea Ciammaruconi; Paola Vacca; Paola Stefanelli
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.